SlideShare a Scribd company logo
Antibiotic policy 2016
‫الحيوية‬ ‫المضادات‬ ‫العليا‬ ‫الجنة‬
made by:
‫مستشفى‬ ‫مدير‬ ‫او‬ ‫قسم‬ ‫رئيس‬ ‫كل‬ ‫من‬ ‫مرشح‬ ‫استف‬ ‫من‬ ‫تتكون‬ ‫التى‬
+
‫د‬
.
‫راشد‬ ‫جمال‬ ‫هللا‬ ‫هبة‬
‫ومشر‬ ‫البكتريا‬ ‫استف‬
‫ادارة‬ ‫على‬ ‫ف‬
‫العدوى‬ ‫مكافحة‬
+
.....
+
‫السابقة‬ ‫السنة‬ ‫خالل‬ ‫المزارع‬ ‫نتايج‬ ‫ومن‬
* Important
* examples in C.N.S. departement
Drug Missusage = Drug resistance
Prevent Antibiotic Resistance:
• Avoid treating viral syndromes with antibiotics
• choose the right antibiotic
• Proper prophylaxis policy
• Pay attention to dose and duration
 Aim of Antibiotic Policy
Reduce the Antimicrobial resistance.
Practice best efforts, these resistance strains do not spill into critically
ill patients in the Hospital.
To prevent spill into Society, as they present as community associated
infections.
 Objectives of Antibiotic Policy
Antibiotics should not be used if unnecessary.
Policy emphasizes, avoiding the use of powerful Antibiotics in the Initial
treatments.
We should create awareness that we are sparing the powerful Broad
spectrum Drugs for later treatment
Patient saves Money
Doctors save Lives
 Hospital Antibiotic Committee
*Clinicians / Microbiologists / Pharmacists and Nurses do take part.
* Policies are framed on demands of the Clinical areas, depending on recent
Infection surveillance data contributed from Microbiology Departments.
- The Pharmacist who will report back to the Antibiotic Committee at each
meeting on drug utilisation and cost.
- The Microbiologist who will report on antibiotic susceptibility patterns of
bacteria isolated from major infections.
- Clinical doctors and nurses responsible for direct patient care who provide a
link between clinical practice and the Antibiotic Committee
- Manger(s) who will ensure the resources are available for implementation of the antibiotic
policy.
- Reciprocal Membership between the Infection Control Committee and the Drugs Committee
should be ensured.
 The policy should
contain guidance on antibiotic prophylaxis (e.g. in surgery with details
of timing, route, dosage and frequency)
contain guidance on the choice of antibiotics for empirical and targeted
therapy of major infections
indicate first and second line therapy for common infections
 Sample collection
Proper specimen collection is combined responsibility of Clinical and
Microbiological Departments.
Continuous training of junior staff on sample collection, and is most
neglected necessity
A good clinical history is greatly helpful in differentiating community
acquired infections from hospital acquired infections.
 Staff Education on Antibiotic Policy
Staff education is most Important principle in success
Induction training for new staff
Continuing Medical Education to both Junior and Senior practioners.
Include nursing staff, pharmacists for the success of the Program
Antibiotic policy
2016
examples in C.N.S. departement
SECTION A
ADULT
CENTRAL NERVOUS INFECTIONS
Comments
Suggested Treatment
Infection/ Condition & Likely organism
Antibiotic treatment must be
started immediately, regardless of
any investigations undertaken…….. If
no organism isolated and patient is
responding, continue antibiotics for
14 days
Alternative
If no clinical
response after 3
days
of antibiotics:
Meropenem 2.0gm
IV q8h.
Dexamethasone
10mg IV q6h is
recommended to
be administered
15 to 20 minutes
before or at the
time of first dose
of antibiotics, for
up to 4 days or
until there is no
evidence of
pneumococcal
meningitis.
Preferred
Empirical
treatment on
admission:
Ceftriaxone 2gm IV
q12h.
OR
Cefotaxime 2-4gm
IV q8h
Meningitis (acute)
Common organisms:
Streptococcus pneumoniae
Neisseria meningitidis
Haemophilus influenzae
Other organisms:
Gram negative rods
Leptospirosis
Scrub typhus
Melioidosis
Mycoplasma pneumoniae
Comments
Suggested Treatment
Infection/ Condition & Likely organism
Alternative
Meropenem 2.0gm
IV q8h
OR
Cefepime 2gm IV
q12h.
If organism is
susceptible:
Chloramphenicol
1gm IV q6h for 14
days.
Preferred
Ceftriaxone 2gm IV
q12h
OR
Cefotaxime 2-4gm
IV q8h
OR
Ceftazidime 2gm
IV q8h.
Duration of
treatment: 10-14
days.
(very ill patients
may require
treatment for 21
days.)
Causative organism isolated:
Haemophilus influenzae
(Gram-ve bacilli)
Comments
Suggested Treatment
Infection/ Condition & Likely organism
For penicillin
resistant strains
Vancomycin 1gm
IV q12h
PLUS
Ceftriaxone 2gm
IV q12h
Relatively-resistant
strains
Ceftriaxone 2gm IV
q12h
Or
Cefotaxime 2-4gm IV
q8h
OR
(either)
Cefotaxime 2-4gm IV
q8h
1. Meropenem 2.0gm IV
q8h
for 10-14 days
2. Cefepime 2gm IV
q12h.
3.Fluroquinolone PLUS
Rifampicin
Duration of treatment:
10-14
days. (very ill patients
may require treatment
for 21 days.)
Penicillin-
sensitive
strains
Benzylpenicill
in 4MU IV q4-
6h for
10-14 days
Causative organism isolated:
Streptococcus pneumoniae
(Gram +ve cocci)
Comments
Suggested Treatment
Infection/ Condition & Likely organism
Close contacts are defined as those
individuals who have had contact
with oropharyngeal secretions
either through kissing or by sharing
toys, beverages, or cigarettes
Alternative
Chloramphenicol
1gm IV q6h.
Ceftriaxone 250mg
IM as single
dose (especially in
pregnancy);
OR
Azithromycin
500mg PO as
single
dose.
Preferred
Ceftriaxone 2gm IV
q12 h
OR
Cefotaxime 2-4gm
IV q8h
OR
Ceftazidime 2gm
IV q8h.
Ciprofloxacin
500mg PO as
single
dose;
OR
Rifampicin 600mg
PO q12h for 2
days (4 doses) [not
recommended
in pregnant
women].
Causative organism isolated:
Neisseria meningitidis
(Gram –ve cocci)
Prophylaxis for household and
close contacts for meningococcal
meningitis
Comments
Suggested Treatment
Infection/ Condition & Likely organism
Ceftriaxone 2gm IV
q12 h
OR
Cefotaxime 2-4gm
IV q8h.
Duration of
treatment: 10-14
days.
(Very ill patients
may require
treatment for 21
days.)
Causative organism isolated:
Gram-negative
Enterobacteriaceae
Comments
Suggested Treatment
Infection/ Condition & Likely organism
Acyclovir 500mg IV
q8h for 14-21
days.
(Duration of
treatment may be
extended to 21 days
in severe cases
or in
immunosuppressed
patients.
:
Viral encephalitis
Herpes simplex
Herpes zoster
Comments
Suggested Treatment
Infection/ Condition & Likely organism
Alternative
Valganciclovir
900mg PO q12h
Valganciclovir PO
900mg PO q24h
for 6 months
depending on
severity
of disease, time to
response and
end organ
involvement.
Preferred
Ganciclovir 5mg/kg
IV q12h for 21
Days
Ganciclovir 5mg/kg
IV q24h for 6
months depending
on severity of
disease, time to
response and end
organ involvement.
May switch to
oral.
Causative organism isolated:
Cytomegalovirus (CMV)
In immunocompromised patients
Induction phase:
Maintenance phase:
Comments
Suggested Treatment
Infection/ Condition & Likely organism
Intensive 2 months S/EHRZ and 10
months HR.
• Isoniazid (H) 5 (4-6) mg/kg/24h
PO
(max: 300 mg/day)
PLUS
• Rifampicin (R) 10 (8-12)
mg/kg/24h PO
(max: 600 mg/day)
PLUS
• Pyrazinamide (Z) 25 (20-30)
mg/kg/24h PO (max: 2000
mg/day)
PLUS
• Streptomycin (S) 15 (12-18)
mg/kg/24h IM (max: 1000adults.
mg/day)
?
Meningitis (chronic)
Tuberculous meningitis
(Mycobacterium tuberculosis)
Comments
Suggested Treatment
Infection/ Condition & Likely
organism
End point of treatment: till at least
total of 1.5-2.0gm of Amphotericin
B given and CSF shows clearance of
fungus by 2 negative C&S one
month apart, and CSF Cryptococcal
antigen titre becomes negative or
at least 1:2 or shows a fourfold
decrease.
Liposomal Amphotericin may be
used in cases of severe toxicity to
Amphotericin B
e.g. Abelcet 3-5mg/kg/day
Alternative
Fluconazole 400mg
IV q24h
initially and then
200-400mg IV
q24h for 6-8 weeks.
Fluconazole
“consolidation”
therapy may be
continued for as
long as 6-12 months,
depending on
the clinical status of
the patient.
Preferred
Amphotericin B 0.7-
1.0mg/kg/24h
IV
PLUS
5-Flucytosine 100-150mg/kg/24h
PO q6h for 2-4 weeks.
Or
Fluconazole 400mg PO q24h
.(If Fluconazole is not tolerated:
Itraconazole 200mg PO q12h)
Fluconazole 400-800mg PO q24h
for 8 weeks.
Cryptococcal meningitis
Cryptococcus neoformans
Induction Therapy:
Consolidation Therapy:
Comments
Suggested Treatment
Infection/ Condition & Likely organism
• Repeat CSF examinations every 6
months. Consider retreatment if cell
count is not decreased in 6 months or
CSF is not entirely normal in 2 years
• All patients with neurosyphilis should be
considered for corticosteroid cover
at the start of the therapy to prevent
the Jarisch-Herxheimer reaction
(Prednisolone 10-20mg PO q8h for
3 days commencing one day prior to
syphilis treatment)
Ceftriaxone 2gm
IM (with Lidocaine
as
diluent) or IV (with
water for injection
as
diluent) for 10-14
days (if no
anaphylaxis
to penicillin)
Aqueous crystalline
penicillin
G, 18-4MU/day,
administered
3 - 4 MU q4h IV for
14 days
OR
Procaine Penicillin
2.4MU IM
q24h
PLUS
Probenecid 500mg
PO q6h for
14 days
Neurosyphilis
SURGICAL CHEMOPROPHYLAXIS
It is the use of antibiotics to prevent infections at the surgical site.
It should be considered when there is significant risk of post-operative infection or where post-operative infection
would have severe consequences.
Ideally, the prophylaxis when given intravenously should be given as soon as the patient is stabilized after induction.
Usually a single dose is sufficient. Asecond dose may be required in the following situations:
a. delay in start of surgery
b. in prolonged operations when the time is more than half of the usual dosing interval of the antibiotic
Pre-operative dose timing: The optimal time for administration of preoperative doses is within 60 minutes before
surgical incision.…Some agents, such as Clindamycin, Fluoroquinolones, Gentamicin, Metronidazole and Vancomycin,
require administration over one to two hours; therefore, the administration of these agents should begin within 120
minutes before surgical incision
Giving more than 1 or 2 doses postoperatively is generally not advised. The practice of continuing prophylactic
antibiotics until surgical drains have been removed is NOT RECOMMENDED.
Comments
Suggested Treatment
Infection/ Condition & Likely organism
Ceftriaxone 2gm IV
single dose one
hour prior to skin
incision
Ceftriaxone 2gm IV
one hour prior to
skin incision,
followed by repeat
dose 1gm IV q12h
till completion of
Surgery
β-Lactam Allergy:
Clindamycin 900mg IV
MRSA colonisation:
Vancomycin 15mg/kg IV
Cefuroxime 1.5gm
IV single dose one
hour prior to skin
incision
Cefuroxime 1.5gm
IV one hour prior
to skin incision,
followed by repeat
dose 750mg IV q8h
till completion of
surgery
Clean (Craniotomy, burrhole for
clean pathology)
< 4 hours
> 4 hours
Comments
Suggested Treatment
Infection/ Condition & Likely organism
Ceftriaxone 2gm IV
one hour prior to
skin incision.
β-Lactam Allergy:
Clindamycin 900mg IV
MRSA colonisation:
Vancomycin 15mg/kg IV
Cefuroxime 1.5gm
IV single dose one
hour prior to skin
incision
Clean + Implant (CSF diversion
procedures e.g. Shunt, EVD,
omaya, DBS, Titanium/acrylic
craniplasty, artificial dura used)
Ceftriaxone 2gm IV
single dose one
hour prior to skin
incision followed
by three repeated
doses of 1gm IV
q12h.
β-Lactam Allergy:
Clindamycin 900mg IV
MRSA colonisation:
Vancomycin 15mg/kg IV
Cefuroxime 1.5gm
IV single dose one
hour prior to skin
incision, followed
by three repeated
doses of 750mg IV
q8h
Clean contaminated
(Transphenoidal, Acosutic
neuroma, involving air sinuses)
Comments
Suggested Treatment
Infection/ Condition & Likely
organism
Ceftriaxone 2gmIV q12h
PLUS/MINUS
Metronidazole 500mg IV q8h for 72
hours.
β-Lactam Allergy:
Clindamycin 900mg IV
MRSA colonisation:
Vancomycin 15mg/kg IV
Cefuroxime 1.5gm IV q8h
PLUS/MINUS
Metronidazole 500mg IV q8h
for 72
hours
Contaminated (Skull fracture,
previous surgery, lacerated scalp)
Meropenem 2gm IV q8h
PLUS/MINUS
Metronidazole 500mg IV q8h
MRSA colonization:
Vancomycin 20mg/kg IV
Pseudomonas infection:
Cefepime 2g IV q8h
OR
Ceftazidime 2g IV q8h
Ceftriaxone 2gm IV q12h
PLUS/MINUS
Metronidazole 500mg IV q8h
For 6-8 weeks depending on
response.
Dirty (brain abscess, subdural
empyema, ventriculitis)
SECTION B
pediatric
Comments
Suggested Treatment
Infection/ Condition & Likely organism
Prophylaxis for all household
contacts if there are unimmunised
or partially immunised children < 4
years old.
If suspected
penicillin-resistant
Strep pneumonia:
Cefotaxime
50mg/kg IV q4-6h
OR
Ceftriaxone for 50-
75mg/kg IV
q12-24h for 10-14
days
PLUS
Vancomycin
15mg/kg IV q6h
Cefotaxime
50mg/kg IV q4-
6h
OR
Ceftriaxone 50-
75mg/kg IV q12-
24h for 10-14
days.
If < 3 month-old,
ADD:
Benzylpenicillin
50mg/kg IVq4-6h
OR
Ampicillin
50mg/kg IV q4-
6h
Meningitis
empirical treatment
Comments
Suggested Treatment
Infection/ Condition & Likely organism
Chloramphenicol 40mg/kg
IV stat
then 25mg/kg q6h for 10-
14 days;
OR
Cefepime 50mg/kg IV q8h
for 10-
14 days
Cefotaxime
50mg/kg IV q4-6h
OR
Ceftriaxone 50-
75mg/kg IV q12-
24h for 10-14
days..)
Causative organism isolated:
Haemophilus influenza
Strepcoccus pneumoniae
Prophylaxis for all household
contacts and Health Care
Workers
involved in intubation and
suctioning of airway
Cefotaxime 50mg/kg IV q4-
6h
OR
Ceftriaxone 50-75mg/kg IV
q12-
24h for 7 days.
OR
Chloramphenicol 40mg/kg
stat
Benzylpenicillin
50mg/kg IV q4-6h
for 7 days
Causative organism isolated:
Neisseria meningitidis
Comments
Suggested Treatment
Infection/ Condition & Likely organism
Amphotericin B
1.0mg/kg/24h IV
PLUS/ MINUS
5-Flucytosine 400-
1200mg/m2
(max 2gm) PO in
q6h for 2-4
weeks.
Fluconazole 10-
12mg/kg/24h PO
in q12h for 8
weeks.
Causative organism isolated:
Cryptococcal meningitis
Cryptococcus neoformans
Induction Therapy:
Consolidation Therapy:
Duration: for 14-21 days.
Acyclovir:
< 12 weeks old:
20mg/kg IV q8h
12 weeks-12 years
old: 500mg/m2
IV q8h
If > 12 years olds:
10mg/kg IV q8h
HerpesSimplexEncephalitis
Comments
Suggested Treatment
Infection/ Condition & Likely organism
Surgical drainage may be indicated
if appropriate.
Duration 6-8 weeks, depending on
response as seen from
neuroimaging.
If secondary to
trauma:
ADD
Cloxacillin 25-
50mg/kg IV q4-6h.
Cefotaxime
50mg/kg IV q4-6h
OR
Ceftriaxone 50-
75mg/kg IV q12-
24h
PLUS
Metronidazole
15mg/kg IV stat
then 7.5mg/kg IV
q8h.
BrainAbscess
Thank you 

More Related Content

Similar to antibiotic policy C.N.S..pptx

Rational use of antibiotics
Rational use of antibiotics Rational use of antibiotics
Rational use of antibiotics
BINDU MADHAVI
 
Therapeutics in dentistry
Therapeutics in dentistryTherapeutics in dentistry
Therapeutics in dentistry
unique associates
 
antibiotic and using in common infection
antibiotic and using in common infection antibiotic and using in common infection
antibiotic and using in common infection
Y Alsfah
 
Antibioitcs guide choice for common infection (doc toon.page)
Antibioitcs guide choice for common infection (doc toon.page)Antibioitcs guide choice for common infection (doc toon.page)
Antibioitcs guide choice for common infection (doc toon.page)
abdullahsharaf55
 
Antibioitcs choices for common infections (2013 edition)
Antibioitcs choices for common infections (2013 edition)Antibioitcs choices for common infections (2013 edition)
Antibioitcs choices for common infections (2013 edition)
Ahmad Ali
 
Antibioitcs guide
Antibioitcs guideAntibioitcs guide
Antibioitcs guide
jeyaprakash jayaraman
 
National guideline for pediatric tb
National guideline for pediatric tbNational guideline for pediatric tb
National guideline for pediatric tb
Dr. Pratik Kumar
 
COVID 19.pptx
COVID 19.pptxCOVID 19.pptx
COVID 19.pptx
Dr.Mohammed Shanil.P
 
Rational use of antibiotics by M. Jagadeesh, Creative Educational Society's C...
Rational use of antibiotics by M. Jagadeesh, Creative Educational Society's C...Rational use of antibiotics by M. Jagadeesh, Creative Educational Society's C...
Rational use of antibiotics by M. Jagadeesh, Creative Educational Society's C...
Dr. Jagadeesh Mangamoori
 
Tb management 2016
Tb management 2016Tb management 2016
Tb management 2016
Haripriya Uppala
 
Antibiotics in Egyptian pharmacies
Antibiotics in Egyptian pharmaciesAntibiotics in Egyptian pharmacies
Antibiotics in Egyptian pharmacies
Ahmed Gamal Afify
 
Antibiotics in dentistry.pptx
Antibiotics in dentistry.pptxAntibiotics in dentistry.pptx
Antibiotics in dentistry.pptx
ssuser71d7b1
 
Rational antibiotic therapy NEW
Rational antibiotic therapy  NEWRational antibiotic therapy  NEW
Rational antibiotic therapy NEW
Sandip Gupta
 
Therapeutics in dentistry (antibiotics)
Therapeutics in dentistry (antibiotics)Therapeutics in dentistry (antibiotics)
Therapeutics in dentistry (antibiotics)
Iyad Abou Rabii
 
21 Antitubercular Agents Updates (pharmacology on line classes)
21 Antitubercular Agents Updates (pharmacology on line classes)21 Antitubercular Agents Updates (pharmacology on line classes)
21 Antitubercular Agents Updates (pharmacology on line classes)
jben501
 
antibiotics-140721032343-phpapp01 (1).pptx
antibiotics-140721032343-phpapp01 (1).pptxantibiotics-140721032343-phpapp01 (1).pptx
antibiotics-140721032343-phpapp01 (1).pptx
ssuserba830c
 
anti TB and othes.pptx
anti TB and othes.pptxanti TB and othes.pptx
anti TB and othes.pptx
DerejeTsegaye8
 
Antibiotic therapy in musculoskeletal infection
Antibiotic therapy in musculoskeletal infectionAntibiotic therapy in musculoskeletal infection
Antibiotic therapy in musculoskeletal infection
NamithRangaswamy
 
Principles of antibiotic use in surgery
Principles of antibiotic use in surgeryPrinciples of antibiotic use in surgery
Principles of antibiotic use in surgery
Drkabiru2012
 
Control of malaria
Control of malariaControl of malaria
Control of malaria
Rangeen Chandran
 

Similar to antibiotic policy C.N.S..pptx (20)

Rational use of antibiotics
Rational use of antibiotics Rational use of antibiotics
Rational use of antibiotics
 
Therapeutics in dentistry
Therapeutics in dentistryTherapeutics in dentistry
Therapeutics in dentistry
 
antibiotic and using in common infection
antibiotic and using in common infection antibiotic and using in common infection
antibiotic and using in common infection
 
Antibioitcs guide choice for common infection (doc toon.page)
Antibioitcs guide choice for common infection (doc toon.page)Antibioitcs guide choice for common infection (doc toon.page)
Antibioitcs guide choice for common infection (doc toon.page)
 
Antibioitcs choices for common infections (2013 edition)
Antibioitcs choices for common infections (2013 edition)Antibioitcs choices for common infections (2013 edition)
Antibioitcs choices for common infections (2013 edition)
 
Antibioitcs guide
Antibioitcs guideAntibioitcs guide
Antibioitcs guide
 
National guideline for pediatric tb
National guideline for pediatric tbNational guideline for pediatric tb
National guideline for pediatric tb
 
COVID 19.pptx
COVID 19.pptxCOVID 19.pptx
COVID 19.pptx
 
Rational use of antibiotics by M. Jagadeesh, Creative Educational Society's C...
Rational use of antibiotics by M. Jagadeesh, Creative Educational Society's C...Rational use of antibiotics by M. Jagadeesh, Creative Educational Society's C...
Rational use of antibiotics by M. Jagadeesh, Creative Educational Society's C...
 
Tb management 2016
Tb management 2016Tb management 2016
Tb management 2016
 
Antibiotics in Egyptian pharmacies
Antibiotics in Egyptian pharmaciesAntibiotics in Egyptian pharmacies
Antibiotics in Egyptian pharmacies
 
Antibiotics in dentistry.pptx
Antibiotics in dentistry.pptxAntibiotics in dentistry.pptx
Antibiotics in dentistry.pptx
 
Rational antibiotic therapy NEW
Rational antibiotic therapy  NEWRational antibiotic therapy  NEW
Rational antibiotic therapy NEW
 
Therapeutics in dentistry (antibiotics)
Therapeutics in dentistry (antibiotics)Therapeutics in dentistry (antibiotics)
Therapeutics in dentistry (antibiotics)
 
21 Antitubercular Agents Updates (pharmacology on line classes)
21 Antitubercular Agents Updates (pharmacology on line classes)21 Antitubercular Agents Updates (pharmacology on line classes)
21 Antitubercular Agents Updates (pharmacology on line classes)
 
antibiotics-140721032343-phpapp01 (1).pptx
antibiotics-140721032343-phpapp01 (1).pptxantibiotics-140721032343-phpapp01 (1).pptx
antibiotics-140721032343-phpapp01 (1).pptx
 
anti TB and othes.pptx
anti TB and othes.pptxanti TB and othes.pptx
anti TB and othes.pptx
 
Antibiotic therapy in musculoskeletal infection
Antibiotic therapy in musculoskeletal infectionAntibiotic therapy in musculoskeletal infection
Antibiotic therapy in musculoskeletal infection
 
Principles of antibiotic use in surgery
Principles of antibiotic use in surgeryPrinciples of antibiotic use in surgery
Principles of antibiotic use in surgery
 
Control of malaria
Control of malariaControl of malaria
Control of malaria
 

Recently uploaded

Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
chandankumarsmartiso
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Donc Test
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 

Recently uploaded (20)

Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 

antibiotic policy C.N.S..pptx

  • 1. Antibiotic policy 2016 ‫الحيوية‬ ‫المضادات‬ ‫العليا‬ ‫الجنة‬ made by: ‫مستشفى‬ ‫مدير‬ ‫او‬ ‫قسم‬ ‫رئيس‬ ‫كل‬ ‫من‬ ‫مرشح‬ ‫استف‬ ‫من‬ ‫تتكون‬ ‫التى‬ + ‫د‬ . ‫راشد‬ ‫جمال‬ ‫هللا‬ ‫هبة‬ ‫ومشر‬ ‫البكتريا‬ ‫استف‬ ‫ادارة‬ ‫على‬ ‫ف‬ ‫العدوى‬ ‫مكافحة‬ + ..... + ‫السابقة‬ ‫السنة‬ ‫خالل‬ ‫المزارع‬ ‫نتايج‬ ‫ومن‬
  • 2. * Important * examples in C.N.S. departement
  • 3. Drug Missusage = Drug resistance
  • 4.
  • 6. • Avoid treating viral syndromes with antibiotics • choose the right antibiotic • Proper prophylaxis policy • Pay attention to dose and duration
  • 7.
  • 8.
  • 9.  Aim of Antibiotic Policy Reduce the Antimicrobial resistance. Practice best efforts, these resistance strains do not spill into critically ill patients in the Hospital. To prevent spill into Society, as they present as community associated infections.
  • 10.  Objectives of Antibiotic Policy Antibiotics should not be used if unnecessary. Policy emphasizes, avoiding the use of powerful Antibiotics in the Initial treatments. We should create awareness that we are sparing the powerful Broad spectrum Drugs for later treatment Patient saves Money Doctors save Lives
  • 11.  Hospital Antibiotic Committee *Clinicians / Microbiologists / Pharmacists and Nurses do take part. * Policies are framed on demands of the Clinical areas, depending on recent Infection surveillance data contributed from Microbiology Departments. - The Pharmacist who will report back to the Antibiotic Committee at each meeting on drug utilisation and cost. - The Microbiologist who will report on antibiotic susceptibility patterns of bacteria isolated from major infections. - Clinical doctors and nurses responsible for direct patient care who provide a link between clinical practice and the Antibiotic Committee - Manger(s) who will ensure the resources are available for implementation of the antibiotic policy. - Reciprocal Membership between the Infection Control Committee and the Drugs Committee should be ensured.
  • 12.  The policy should contain guidance on antibiotic prophylaxis (e.g. in surgery with details of timing, route, dosage and frequency) contain guidance on the choice of antibiotics for empirical and targeted therapy of major infections indicate first and second line therapy for common infections
  • 13.  Sample collection Proper specimen collection is combined responsibility of Clinical and Microbiological Departments. Continuous training of junior staff on sample collection, and is most neglected necessity A good clinical history is greatly helpful in differentiating community acquired infections from hospital acquired infections.
  • 14.  Staff Education on Antibiotic Policy Staff education is most Important principle in success Induction training for new staff Continuing Medical Education to both Junior and Senior practioners. Include nursing staff, pharmacists for the success of the Program
  • 18. Comments Suggested Treatment Infection/ Condition & Likely organism Antibiotic treatment must be started immediately, regardless of any investigations undertaken…….. If no organism isolated and patient is responding, continue antibiotics for 14 days Alternative If no clinical response after 3 days of antibiotics: Meropenem 2.0gm IV q8h. Dexamethasone 10mg IV q6h is recommended to be administered 15 to 20 minutes before or at the time of first dose of antibiotics, for up to 4 days or until there is no evidence of pneumococcal meningitis. Preferred Empirical treatment on admission: Ceftriaxone 2gm IV q12h. OR Cefotaxime 2-4gm IV q8h Meningitis (acute) Common organisms: Streptococcus pneumoniae Neisseria meningitidis Haemophilus influenzae Other organisms: Gram negative rods Leptospirosis Scrub typhus Melioidosis Mycoplasma pneumoniae
  • 19. Comments Suggested Treatment Infection/ Condition & Likely organism Alternative Meropenem 2.0gm IV q8h OR Cefepime 2gm IV q12h. If organism is susceptible: Chloramphenicol 1gm IV q6h for 14 days. Preferred Ceftriaxone 2gm IV q12h OR Cefotaxime 2-4gm IV q8h OR Ceftazidime 2gm IV q8h. Duration of treatment: 10-14 days. (very ill patients may require treatment for 21 days.) Causative organism isolated: Haemophilus influenzae (Gram-ve bacilli)
  • 20. Comments Suggested Treatment Infection/ Condition & Likely organism For penicillin resistant strains Vancomycin 1gm IV q12h PLUS Ceftriaxone 2gm IV q12h Relatively-resistant strains Ceftriaxone 2gm IV q12h Or Cefotaxime 2-4gm IV q8h OR (either) Cefotaxime 2-4gm IV q8h 1. Meropenem 2.0gm IV q8h for 10-14 days 2. Cefepime 2gm IV q12h. 3.Fluroquinolone PLUS Rifampicin Duration of treatment: 10-14 days. (very ill patients may require treatment for 21 days.) Penicillin- sensitive strains Benzylpenicill in 4MU IV q4- 6h for 10-14 days Causative organism isolated: Streptococcus pneumoniae (Gram +ve cocci)
  • 21. Comments Suggested Treatment Infection/ Condition & Likely organism Close contacts are defined as those individuals who have had contact with oropharyngeal secretions either through kissing or by sharing toys, beverages, or cigarettes Alternative Chloramphenicol 1gm IV q6h. Ceftriaxone 250mg IM as single dose (especially in pregnancy); OR Azithromycin 500mg PO as single dose. Preferred Ceftriaxone 2gm IV q12 h OR Cefotaxime 2-4gm IV q8h OR Ceftazidime 2gm IV q8h. Ciprofloxacin 500mg PO as single dose; OR Rifampicin 600mg PO q12h for 2 days (4 doses) [not recommended in pregnant women]. Causative organism isolated: Neisseria meningitidis (Gram –ve cocci) Prophylaxis for household and close contacts for meningococcal meningitis
  • 22. Comments Suggested Treatment Infection/ Condition & Likely organism Ceftriaxone 2gm IV q12 h OR Cefotaxime 2-4gm IV q8h. Duration of treatment: 10-14 days. (Very ill patients may require treatment for 21 days.) Causative organism isolated: Gram-negative Enterobacteriaceae
  • 23. Comments Suggested Treatment Infection/ Condition & Likely organism Acyclovir 500mg IV q8h for 14-21 days. (Duration of treatment may be extended to 21 days in severe cases or in immunosuppressed patients. : Viral encephalitis Herpes simplex Herpes zoster
  • 24. Comments Suggested Treatment Infection/ Condition & Likely organism Alternative Valganciclovir 900mg PO q12h Valganciclovir PO 900mg PO q24h for 6 months depending on severity of disease, time to response and end organ involvement. Preferred Ganciclovir 5mg/kg IV q12h for 21 Days Ganciclovir 5mg/kg IV q24h for 6 months depending on severity of disease, time to response and end organ involvement. May switch to oral. Causative organism isolated: Cytomegalovirus (CMV) In immunocompromised patients Induction phase: Maintenance phase:
  • 25. Comments Suggested Treatment Infection/ Condition & Likely organism Intensive 2 months S/EHRZ and 10 months HR. • Isoniazid (H) 5 (4-6) mg/kg/24h PO (max: 300 mg/day) PLUS • Rifampicin (R) 10 (8-12) mg/kg/24h PO (max: 600 mg/day) PLUS • Pyrazinamide (Z) 25 (20-30) mg/kg/24h PO (max: 2000 mg/day) PLUS • Streptomycin (S) 15 (12-18) mg/kg/24h IM (max: 1000adults. mg/day) ? Meningitis (chronic) Tuberculous meningitis (Mycobacterium tuberculosis)
  • 26. Comments Suggested Treatment Infection/ Condition & Likely organism End point of treatment: till at least total of 1.5-2.0gm of Amphotericin B given and CSF shows clearance of fungus by 2 negative C&S one month apart, and CSF Cryptococcal antigen titre becomes negative or at least 1:2 or shows a fourfold decrease. Liposomal Amphotericin may be used in cases of severe toxicity to Amphotericin B e.g. Abelcet 3-5mg/kg/day Alternative Fluconazole 400mg IV q24h initially and then 200-400mg IV q24h for 6-8 weeks. Fluconazole “consolidation” therapy may be continued for as long as 6-12 months, depending on the clinical status of the patient. Preferred Amphotericin B 0.7- 1.0mg/kg/24h IV PLUS 5-Flucytosine 100-150mg/kg/24h PO q6h for 2-4 weeks. Or Fluconazole 400mg PO q24h .(If Fluconazole is not tolerated: Itraconazole 200mg PO q12h) Fluconazole 400-800mg PO q24h for 8 weeks. Cryptococcal meningitis Cryptococcus neoformans Induction Therapy: Consolidation Therapy:
  • 27. Comments Suggested Treatment Infection/ Condition & Likely organism • Repeat CSF examinations every 6 months. Consider retreatment if cell count is not decreased in 6 months or CSF is not entirely normal in 2 years • All patients with neurosyphilis should be considered for corticosteroid cover at the start of the therapy to prevent the Jarisch-Herxheimer reaction (Prednisolone 10-20mg PO q8h for 3 days commencing one day prior to syphilis treatment) Ceftriaxone 2gm IM (with Lidocaine as diluent) or IV (with water for injection as diluent) for 10-14 days (if no anaphylaxis to penicillin) Aqueous crystalline penicillin G, 18-4MU/day, administered 3 - 4 MU q4h IV for 14 days OR Procaine Penicillin 2.4MU IM q24h PLUS Probenecid 500mg PO q6h for 14 days Neurosyphilis
  • 28. SURGICAL CHEMOPROPHYLAXIS It is the use of antibiotics to prevent infections at the surgical site. It should be considered when there is significant risk of post-operative infection or where post-operative infection would have severe consequences. Ideally, the prophylaxis when given intravenously should be given as soon as the patient is stabilized after induction. Usually a single dose is sufficient. Asecond dose may be required in the following situations: a. delay in start of surgery b. in prolonged operations when the time is more than half of the usual dosing interval of the antibiotic Pre-operative dose timing: The optimal time for administration of preoperative doses is within 60 minutes before surgical incision.…Some agents, such as Clindamycin, Fluoroquinolones, Gentamicin, Metronidazole and Vancomycin, require administration over one to two hours; therefore, the administration of these agents should begin within 120 minutes before surgical incision Giving more than 1 or 2 doses postoperatively is generally not advised. The practice of continuing prophylactic antibiotics until surgical drains have been removed is NOT RECOMMENDED.
  • 29. Comments Suggested Treatment Infection/ Condition & Likely organism Ceftriaxone 2gm IV single dose one hour prior to skin incision Ceftriaxone 2gm IV one hour prior to skin incision, followed by repeat dose 1gm IV q12h till completion of Surgery β-Lactam Allergy: Clindamycin 900mg IV MRSA colonisation: Vancomycin 15mg/kg IV Cefuroxime 1.5gm IV single dose one hour prior to skin incision Cefuroxime 1.5gm IV one hour prior to skin incision, followed by repeat dose 750mg IV q8h till completion of surgery Clean (Craniotomy, burrhole for clean pathology) < 4 hours > 4 hours
  • 30. Comments Suggested Treatment Infection/ Condition & Likely organism Ceftriaxone 2gm IV one hour prior to skin incision. β-Lactam Allergy: Clindamycin 900mg IV MRSA colonisation: Vancomycin 15mg/kg IV Cefuroxime 1.5gm IV single dose one hour prior to skin incision Clean + Implant (CSF diversion procedures e.g. Shunt, EVD, omaya, DBS, Titanium/acrylic craniplasty, artificial dura used) Ceftriaxone 2gm IV single dose one hour prior to skin incision followed by three repeated doses of 1gm IV q12h. β-Lactam Allergy: Clindamycin 900mg IV MRSA colonisation: Vancomycin 15mg/kg IV Cefuroxime 1.5gm IV single dose one hour prior to skin incision, followed by three repeated doses of 750mg IV q8h Clean contaminated (Transphenoidal, Acosutic neuroma, involving air sinuses)
  • 31. Comments Suggested Treatment Infection/ Condition & Likely organism Ceftriaxone 2gmIV q12h PLUS/MINUS Metronidazole 500mg IV q8h for 72 hours. β-Lactam Allergy: Clindamycin 900mg IV MRSA colonisation: Vancomycin 15mg/kg IV Cefuroxime 1.5gm IV q8h PLUS/MINUS Metronidazole 500mg IV q8h for 72 hours Contaminated (Skull fracture, previous surgery, lacerated scalp) Meropenem 2gm IV q8h PLUS/MINUS Metronidazole 500mg IV q8h MRSA colonization: Vancomycin 20mg/kg IV Pseudomonas infection: Cefepime 2g IV q8h OR Ceftazidime 2g IV q8h Ceftriaxone 2gm IV q12h PLUS/MINUS Metronidazole 500mg IV q8h For 6-8 weeks depending on response. Dirty (brain abscess, subdural empyema, ventriculitis)
  • 33. Comments Suggested Treatment Infection/ Condition & Likely organism Prophylaxis for all household contacts if there are unimmunised or partially immunised children < 4 years old. If suspected penicillin-resistant Strep pneumonia: Cefotaxime 50mg/kg IV q4-6h OR Ceftriaxone for 50- 75mg/kg IV q12-24h for 10-14 days PLUS Vancomycin 15mg/kg IV q6h Cefotaxime 50mg/kg IV q4- 6h OR Ceftriaxone 50- 75mg/kg IV q12- 24h for 10-14 days. If < 3 month-old, ADD: Benzylpenicillin 50mg/kg IVq4-6h OR Ampicillin 50mg/kg IV q4- 6h Meningitis empirical treatment
  • 34. Comments Suggested Treatment Infection/ Condition & Likely organism Chloramphenicol 40mg/kg IV stat then 25mg/kg q6h for 10- 14 days; OR Cefepime 50mg/kg IV q8h for 10- 14 days Cefotaxime 50mg/kg IV q4-6h OR Ceftriaxone 50- 75mg/kg IV q12- 24h for 10-14 days..) Causative organism isolated: Haemophilus influenza Strepcoccus pneumoniae Prophylaxis for all household contacts and Health Care Workers involved in intubation and suctioning of airway Cefotaxime 50mg/kg IV q4- 6h OR Ceftriaxone 50-75mg/kg IV q12- 24h for 7 days. OR Chloramphenicol 40mg/kg stat Benzylpenicillin 50mg/kg IV q4-6h for 7 days Causative organism isolated: Neisseria meningitidis
  • 35. Comments Suggested Treatment Infection/ Condition & Likely organism Amphotericin B 1.0mg/kg/24h IV PLUS/ MINUS 5-Flucytosine 400- 1200mg/m2 (max 2gm) PO in q6h for 2-4 weeks. Fluconazole 10- 12mg/kg/24h PO in q12h for 8 weeks. Causative organism isolated: Cryptococcal meningitis Cryptococcus neoformans Induction Therapy: Consolidation Therapy: Duration: for 14-21 days. Acyclovir: < 12 weeks old: 20mg/kg IV q8h 12 weeks-12 years old: 500mg/m2 IV q8h If > 12 years olds: 10mg/kg IV q8h HerpesSimplexEncephalitis
  • 36. Comments Suggested Treatment Infection/ Condition & Likely organism Surgical drainage may be indicated if appropriate. Duration 6-8 weeks, depending on response as seen from neuroimaging. If secondary to trauma: ADD Cloxacillin 25- 50mg/kg IV q4-6h. Cefotaxime 50mg/kg IV q4-6h OR Ceftriaxone 50- 75mg/kg IV q12- 24h PLUS Metronidazole 15mg/kg IV stat then 7.5mg/kg IV q8h. BrainAbscess